SCN5A and Ventricular arrhythmia: Pathogenic/likely pathogenic variants in SCN5A are associated with a substantially higher burden of atrial and ventricular arrhythmias (in >90% of cases), cardiac conduction disease, and higher risk of sudden cardiac death [12,14,15,16].